The antiapoptotic proteins Mcl-1 and Bcl-2 have been shown to be critical in T-cell development and homeostasis, but the precise mechanism by which these proteins function in T cells and other cells of the body is unclear. Potential mechanisms have allowed both for overlapping and unique roles for these proteins because of their abilities to bind different proapoptotic Bcl-2 family members, but it is unclear which of these mechanisms are important in an in vivo context. By generation of various genetic mouse models, we found that Mcl-1-deficient thymocytes die largely by a Bak-specific mechanism. In vivo deletion of Bak rescued the survival and developmental blocks of Mcl-1-deficient thymocytes at the double-negative and single-positive stages. Transgenic overexpression of Bcl-2 and in vivo deletion of Bax or Bim were unable to rescue Mcl-1-deficient thymocytes. Thus, Mcl-1 functions in a unique pathway from Bcl-2 in T lymphocytes, likely because of its specific ability to bind and sequester proapoptotic Bak. Together, these data provide an in vivo model for Mcl-1 activity and present us with a greater understanding of the pathways that promote thymocyte survival.
T lymphocytes are a dynamic population that depends on the careful regulation of apoptotic pathways for both its establishment and maintenance. In the thymus, hematopoietic precursors undergo a multistage developmental program, in which cells progress from the immature CD4 À CD8 À doublenegative (DN) stage, through the CD4 þ CD8 þ double-positive (DP) stage, to CD4 þ CD8 À or CD4 À CD8 þ single-positive (SP) stages before exiting the thymus into the peripheral T-cell pool. During this process, thymocytes undergo multiple selection steps to ensure that a functional, non-self-reactive T-cell receptor (TCR) is expressed on the cell surface. Classical apoptotic pathways have essential roles in thymic selection and peripheral responses, with critical implications for autoimmunity and homeostasis. 1 Bcl-2 family proteins, which are mediators of the intrinsic pathway of apoptosis, are defined by sharing one or more of four Bcl-2 homology (BH) domains and can be subdivided into the following three subgroups by structure and function: multidomain antiapoptotic proteins, multidomain proapoptotic proteins, and proapoptotic BH3-only proteins. 2 The antiapoptotic proteins, namely Bcl-2, Mcl-1, Bcl-x L , Bcl-w, and A1, share multiple BH regions and inhibit proapoptotic family members through interactions between BH domains. Proapoptotic Bak and Bax, which contain BH1-3 regions, form homo-oligomeric pores in the mitochondrial membrane and are critical for the release of cytochrome c and downstream events, such as activation of Apaf-1 and effector caspases. 3, 4 BH3-only proteins function as sensors of apoptotic stimuli and induce apoptosis either by directly activating Bak and Bax ('activators') or by binding antiapoptotic proteins ('sensitizers'), although the extent to which they have these different roles in vivo is still unclear. [5] [6] [7] [8] [9] [10] [11] Genetic mouse models have suggested distinct roles for antiapoptotic proteins in T lymphocytes. Bcl-2 À/À thymocyte development is normal at early postnatal time points, but T cells in both the periphery and the thymus are lost by 4 weeks of age, likely because of differences in Bcl-2 dependency between fetal liver and bone marrow-derived hematopoietic progenitors. [12] [13] [14] [15] However, Bcl-x L is not required for T-cell development, effector function or memory, although Bcl-x À/À DP thymocytes have reduced survival under some conditions. [16] [17] [18] Mcl-1 is required for thymocyte progression past the DN stage and is also required for SP cells to reach maturation and for survival of naive and activated peripheral T cells. 19, 20 Mcl-1, Bcl-2, and Bcl-x L are each expressed in a unique pattern in thymocytes. Mcl-1 is expressed in all thymocyte subsets. 19, 20 Bcl-2 is expressed in both DN and SP stages, but downregulated in DP until positive selection. [21] [22] [23] Conversely, Bcl-x L , the predominant splice product of the Bcl-x gene in thymocytes, exhibits high expression at DP but low expression at DN and SP. 16, 24 Given that Mcl-1 and Bcl-2 are expressed in DN and SP thymocytes, [20] [21] [22] [23] it was intriguing that loss of Mcl-1 alone did not allow survival past these stages. 19, 20 As Bcl-2 À/À thymocytes show a similar defect, [12] [13] [14] [15] it seems that both Bcl-2 and Mcl-1 are singly required for survival past the DN stage. This raised the question of whether Bcl-2 and Mcl-1 have distinct molecular roles in thymocytes. To assess this, we generated genetic models to dissect the mechanisms of Mcl-1 activity. These studies will not only yield insight into mechanisms of thymocyte survival but also have implications for understanding how different types of Bcl-2 family members regulate apoptosis in vivo.
Results
Genetic models for dissecting the roles of Mcl-1. We previously developed an Mcl-1 deletion model in which exon 1 of the Mcl-1 gene was flanked by loxP recombination sites to create 'floxed' mice (Mcl-1 f/f ). 25 To achieve deletion at different stages in thymic development, these mice were crossed with mice in which Cre recombinase is expressed under the proximal Lck promoter, which allows efficient deletion by the DN3 stage, or mice expressing Cre under the CD4 promoter/enhancer, which deletes by DP. 20, 26 27 Flow cytometry confirmed expression of the Bcl-2 transgene in DN, DP, and SP thymocytes in our system (data not shown).
In these and previous experiments, Mcl-1 f/f LckCre mice exhibited a dramatic reduction (B90%) in total thymocyte number attributed to a block at DN, specifically an accumulation at the CD44 þ CD25 þ DN2 and CD44 À CD25 þ DN3 stages (Figure 1) . 20 A similarly profound loss in thymocyte number was observed in Mcl-1 f/f LckCreBcl-2 tg mice compared with both Bcl-2 tg and wild-type controls ( Figure 1a ). In spite of increased thymic cellularity in Bcl-2 tg control mice, Mcl-1 f/f LckCreBcl-2 tg total cell numbers were not significantly different from those of Mcl-1 f/f LckCre mice ( Figure 1a) . As previously observed, the thymic profile of Mcl-1 f/f LckCre mice showed a skewing toward the DN compartment at the expense of DP (Figure 1b, upper (Figure 1f , right). The same results were observed for CD4 þ and CD8 þ T cells, respectively, in the spleen (Figure 1g ). These data show that although overexpression of Bcl-2 lends a modest improvement to survival of Mcl-1-deficient SP thymocytes and peripheral T cells, particularly CD4 þ cells, there is still a significant impairment in the survival of these cells as the transgene is unable to rescue percentages to wild-type or Bcl-2 tg control levels.
LckCre mice, whereas Bax À/À cannot. One explanation for the nonredundancy of Mcl-1 and Bcl-2 is that these proteins have differential abilities to bind proapoptotic proteins. For example, the BH3-only protein Noxa binds Mcl-1 and A1 but not Bcl-2 or Bcl-x L .
6,9 Intriguingly, Bak has been shown to bind Mcl-1 at relatively high affinity, Bcl-x L at a lower affinity, and did not bind Bcl-2 to a detectable level. 31 However, a different group recently showed that when the Bak protein as opposed to the Bak BH3 peptide 31 was used, Bcl-2 could bind Bak with similar or better affinity than Bcl-x L , although this was somewhat dependent on the variant of Bcl-2. 32 Therefore, the in vivo specificity of Bak for Mcl-1 is unclear. To determine whether the death of Mcl-1-deficient thymocytes occurred preferentially through Bak, we crossed Mcl-1 f/f LckCre mice with Bak À/À and Bax
mice. Although some groups, but not others, have observed a mild expansion in total cellularity of the Bax À/À thymus, 29, 33 we observed no differences between wild-type and Bak or Bax single knockouts (not shown), and therefore all Crenegative genotypes are represented as controls in our experiments. 
CD4CreBcl-2 tg mice from the spleen (i), thymus (ii), CD4 þ SP-gated thymocytes (iii), and CD8 þ SP thymocytes (iv). Qa2 versus CD69 SP plots were pregated on TCRb þ . Numbers represent the percentage of total (i, ii) or pregated populations (iii, iv , and Mcl-1 . n ¼ 8-11 (Bak) and n ¼ 3-10 (Bax); ns, not significant; P-value is illustrated as *Po0.05, **Po0.01, ***Po0.001 CD4Cre mice had normal cellularity and this was unaltered by deletion of Bak or Bax (Figure 3a) . The percentage of T cells in the Mcl-1 f/f CD4CreBak À/À spleen returned to near control levels, and a partial increase over Mcl-1 f/f CD4Cre was observed in mice heterozygous for Bak (Figure 3b) (Figure 3f and g ).
Loss of Bim does not rescue Mcl-1-deficient thymocytes.
One of the proposed roles of antiapoptotic proteins is to inhibit BH3-only proteins, such as Bim, that are capable of directly activating Bak and Bax. 7, 8 Bim is known to be critical for preventing autoimmunity because of its roles in thymocyte-negative selection and activated T cells. (Figure 5a ). [8] [9] [10] By this model, certain BH3-only molecules, namely Bim, Bid, and possibly Puma, directly activate Bak and Bax and binding of the antiapoptotic proteins to these BH3-only activators inhibits apoptotic pathways. [8] [9] [10] Alternatively, under the 'Bak/Bax sequestration' model, the antiapoptotic proteins function to bind Bak and Bax directly to prevent their oligomerization and/or activation (Figure 5b) . 5 By this model, all BH3-only proteins function upstream to affect the ability of antiapoptotic proteins to bind Bak/Bax and the distinction between 'activators' and 'sensitizers' really lies in the differential abilities of the BH3-only proteins to bind antiapoptotic proteins. CD4CreBim. Mice were 4-8 weeks of age and represent four separate experiments. n ¼ 4-7; ns, not significant; P-value is illustrated as *Po0.05, **Po0.01, ***Po0.001
One limitation of the studies leading to these models is that specific interactions between the Bcl-2 family members have been largely defined using BH3 peptides and were performed in cell lines, 6, 31 and further studies are required to examine the in vivo consequences of these interactions. Recent data obtained from knock-in mice expressing mutant forms of Bim suggest that both its ability to bind antiapoptotic proteins (indirect activation) and its ability to bind Bax (direct activation) are important for its full apoptotic effects. 11 The data we presented in this study allow us to build an in vivo pathway of the roles of Mcl-1 in thymocytes (Figure 5c ). Our data support previous biochemical data showing specificity at the level of the Mcl-1-Bak interaction. 31 Together, these results are supportive of a model in which Mcl-1 directly sequesters Bak in thymocytes. We showed that loss of the direct activator Bim does not rescue Mcl-1-deficient thymocytes, although this does not rule out the possibility that other BH3-only 'activators' may be downstream of Mcl-1. However, Bid and Puma have both been shown to activate Bax and Bak, 3, 10 and our data show that Mcl-1-deficient thymocytes die by a Bak-specific mechanism. Release of BH3-only proteins upon deletion of Mcl-1 may still contribute to the death of thymocytes, particularly in DN cells in which rescue by Bak À/À was incomplete. It is possible that one of these BH3-only proteins could preferentially activate Bak over Bax, either directly or indirectly, by a mechanism that is yet to be appreciated. Future studies should continue to explore which other Bcl-2-family proteins contribute to the death of Mcl-1-deficient cells. However, the robust rescue by Bak À/À is suggestive of a major role of Mcl-1 in thymocytes being that of directly antagonizing Bak. Figure 5c ). Although our data do not directly address the role of Bcl-2, published data place Bim genetically downstream of Bcl-2, and suggest that the major role of Bcl-2 in thymocytes is to inhibit the activation of Bax and/or Bak by Bim (Bax activation displayed in Figure 5c) Nonredundancy of Bcl-2 family members. The rescue of Mcl-1-deficient thymocytes by the Bak knockout mice was somewhat surprising considering that Bak and Bax are presumed to be largely redundant. 28 Neither Bak nor Bax single knockout mice display a significant phenotype, whereas the double knockout mice have profound defects in several systems, including thymocytes. 28, 29, 33 However, there is some evidence that Bak and Bax, although performing similar functions, may be regulated differently. Under resting conditions, Bak is localized on the mitochondrial membrane, whereas Bax can be found in the cytosol until induction of apoptosis when it relocates to the mitochondrial membrane, coincident with a conformational shift to the active form and multimerization. [38] [39] [40] Although hard evidence is still required, on a conceptual level, this could allow for Bak and Bax to be subjected to different regulatory mechanisms. In addition, although our study focuses on the roles of the Bcl-2 family members, other proteins may affect the activity of Bak and/or Bax. Mitochondrial protein VDAC2 has been shown to bind monomeric Bak in the mitochondrial membrane and contribute to the susceptibility of cells to apoptosis through Bak. 41, 42 44 Mcl-1-deficient neutrophils were not rescued by Bim À/À , but Bim À/À could rescue activated Mcl-1-deficient macrophages in their system. 44 The reasons for differences in the roles of Mcl-1 between different cell types are not yet clear. However, as the balance between antiapoptotic and proapoptotic factors is what ultimately determines cell fate, a likely contributor would be differences in expression and activity of other Bcl-2 family members between cell types. Upstream BH3-only proteins inhibit antiapoptotic proteins and can combine to sensitize the cell toward certain stimuli. For example, although neither Noxa nor Bad alone could cause apoptosis in certain experimental systems, the coexpression of these proteins or their BH3 regions led to cell death. 6, 31 Bad has been shown to bind Bcl-2 and Bcl-x L but not Mcl-1 directly, whereas Noxa binds Mcl-1 and A1 but not Bcl-x L or Bcl-2. 6 Thus, Bad could indirectly influence the role of Mcl-1 in that the more Bad activity there is in a cell, the less Bcl-2 and Bcl-x L are able to perform shared roles with Mcl-1 and the more susceptible the cell becomes to loss of Mcl-1 protein or function. In addition, the activity of Noxa, which inhibits Mcl-1, is likely to have a large role in determining the availability of Mcl-1 to perform its specific roles as well as shared roles with Bcl-2. As biochemical pathways are further defined, it will be important to consider that each cell type and condition may have a different balance of Bcl-2 family members. Given the importance of the Bcl-2 family in lymphoid and other systems, as well as the current interest in this family as targets of cancer therapy, it will be critical to continue to delineate roles of antiapoptotic proteins in vivo in different cell types.
Materials and Methods
Mice. Generation of Mcl-1 f/f mice was previously described. 25 Mcl-1-floxed mice were backcrossed seven generations with C57BL/6 mice. LckCre and CD4Cre mice 26 were obtained from Taconic (Hudson, NY, USA). Bak, 28 Bax, 29 and Bim 30
